BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 3908727)

  • 61. [Double-blind comparison of L-keflex and cephalexin (Keflex) in dental infections (author's transl)].
    Horii M; Morinaga T; Shimada S; Takeuchi T; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Ikeda S; Takada S; Iizuka O; Kimura J; Sagara S; Inada Y; Nishioka Y; Kimata M
    Jpn J Antibiot; 1980 Nov; 33(11):1194-214. PubMed ID: 7017189
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
    Leveque B; Lambert-Zechovsky N; Cathlin C
    Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
    [No Abstract]   [Full Text] [Related]  

  • 63. In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem.
    Sato K; Okachi R; Matsukuma I; Mochida K; Hirata T
    J Antibiot (Tokyo); 1989 Dec; 42(12):1844-53. PubMed ID: 2621166
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical study of S 6472 in urinary tract infection].
    Takagi S; Arakawa S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Ishigami J; Umezu K; Yamanaka N; Sugimoto M
    Jpn J Antibiot; 1990 Nov; 43(11):1850-72. PubMed ID: 2287054
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of acute bronchitis and pneumonia with cefaclor.
    Mattson K; Renkonen OV; Laitinen L; Nikander-Hurme R
    Postgrad Med J; 1979; 55 Suppl 4():59-61. PubMed ID: 398482
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of complicated urinary tract infections in men and women.
    Kawada Y
    Infection; 1994; 22 Suppl 1():S55-7. PubMed ID: 8050798
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Cefaclor dosage change with renal dysfunction].
    Usuda Y; Sekine O
    Jpn J Antibiot; 1985 Apr; 38(4):1141-6. PubMed ID: 4032725
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor.
    Parish LC; Aten EM
    Cutis; 1984 Dec; 34(6):567-70. PubMed ID: 6394217
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis.
    Randolph MF
    Chemotherapy; 1988; 34(6):512-8. PubMed ID: 3243093
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cefaclor in the treatment of uncomplicated gonococcal urethritis.
    Harrison WO
    Postgrad Med J; 1979; 55 Suppl 4():85-7. PubMed ID: 121455
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Three-day and seven-day treatment in acute otitis media: a double-blind antibiotic trial.
    Jones R; Bain J
    J R Coll Gen Pract; 1986 Aug; 36(289):356-8. PubMed ID: 3735223
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
    Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
    Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora.
    Iravani A; Richard GA
    Antimicrob Agents Chemother; 1986 Jan; 29(1):107-11. PubMed ID: 3524418
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Cefaclor and trimethoprim-sulfamethoxazole for recurrent otitis media].
    Fliss DM; Krauss M; Gorodischer R; Bearman J; Lieberman A
    Harefuah; 1989 Dec; 117(11):361-3. PubMed ID: 2695415
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative trials of cefaclor AF in uncomplicated cystitis and asymptomatic bacteriuria.
    Hamilton-Miller JM; Iravani A; Brumfitt W; Byers KS; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S60-6; discussion S66-7. PubMed ID: 1287620
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of cefaclor.
    Derry JE
    Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections].
    Spath P
    Wien Med Wochenschr; 1983 Jan; 133(1):27-30. PubMed ID: 6837048
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A; Longest KA; Senetar JE; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Pharmacokinetic and clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].
    Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Sakata Y; Fujimoto T; Yokochi K; Yamashita F
    Jpn J Antibiot; 1989 Jul; 42(7):1629-66. PubMed ID: 2681864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.